Toxogonin (Obidoxime chloride) 250 mg (W6369-22-A052)
Process Number PW-21-00979021
Dates:
2021-12-17 00:00:00
Amendment date:None
Date closing:2022/01/28 14:00 Eastern Standard Time (EST)
Details:
Ontario
Department of National Defence
Department of National Defence
National Capital Region
Open
PW-21-00979021
W6369-22-A052
Description:
Department of National Defence, has a requirement for Toxogonin (Obidoxime chloride) 250 mg for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to chemical warfare agents. The period of the Contract is from date of Contract to 31 March 2024 inclusive. Initial Requirement: The Contractor must supply 4,110 vials or ampoules no later than 31 March 2022. Optional Requirements a. Optional Requirement 1: The Contractor must supply up to 4,110 vials or ampoules no later than 31 March 2023. b. Optional Requirement 2: The Contractor must supply up to 4,110 vials or ampoules no later than 31 March 2024.
Contact information:
Ibrahim, Lana
Contact email:LANA.IBRAHIM@forces.gc.ca
Contact phone:101 Colonel By Drive Ottawa ON K1A 0K2 CA
Contact Fax:Solicitation Documents:
| File | Amendment Number | Language | Date added |
|---|---|---|---|
| w6369-22-a052-ddp_fr.pdf | 000 | French | 2021-12-17 |
| w6369-22-a052-rfp_en.pdf | 000 | English | 2021-12-17 |